Malignant Solid Neoplasm Clinical Trials in Portland, Oregon

10 studies are recruiting for malignant solid neoplasm in Portland, Oregon right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

    This phase II ComboMATCH treatment trial compares the effect of neratinib to the combination of neratinib and palbociclib in treating patients with HER2 positive solid tumors. Neratinib and palbociclib are in a class of medications called kinase inhibitors. They work by blocking the action of an ab…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Providence Portland Medical Center, Portland, Oregon
    Locations
    194 in total
    Run by
    National Cancer Institute (NCI)
  2. Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

    This study collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, preven…

    Stage
    Not phased
    Ages
    Any age
    Site
    Providence Portland Medical Center, Portland, Oregon
    Locations
    625 in total
    Run by
    Alliance for Clinical Trials in Oncology
  3. Observational Study of Sex Differences in Symptoms During Immune Checkpoint Inhibitor Treatment for People With Cancer

    This study aims to learn more about symptoms that patients experience while receiving immunotherapy for cancer.

    Stage
    Not phased
    Ages
    18 and older
    Site
    OHSU Knight Cancer Institute, Portland, Oregon
    Run by
    OHSU Knight Cancer Institute
  4. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the earl…

    Stage
    Not phased
    Ages
    40 to 75
    Site
    Providence Portland Medical Center, Portland, Oregon
    Locations
    745 in total
    Run by
    Alliance for Clinical Trials in Oncology
  5. Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer

    This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with alkylating agents. Alkylating agents are part of standard chemotherapy, but may cause damage to the ovaries. I…

    Stage
    Phase 3
    Ages
    Up to 39
    Site
    Oregon Health and Science University, Portland, Oregon
    Locations
    206 in total
    Run by
    Children's Oncology Group
  6. Project: Every Child for Younger Patients With Cancer

    This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.

    Stage
    Not phased
    Ages
    Up to 25
    Site
    Legacy Emanuel Children's Hospital, Portland, Oregon
    Locations
    279 in total
    Run by
    Children's Oncology Group
  7. CREATE: Art for Children With Cancer

    This clinical trial is being done to develop and test how well creative arts interventions (drawing, painting, making sculptures) compared to watching videos can affect symptoms and impact the quality of life in children with cancer. Creative arts mind-body interventions (CrA) are one type of compl…

    Stage
    Not phased
    Ages
    8 to 13
    Site
    OHSU Knight Cancer Institute, Portland, Oregon
    Run by
    OHSU Knight Cancer Institute
  8. Identifying and Caring for Individuals With Inherited Cancer Syndrome

    This trial examines approaches to identify and care for individuals with inherited cancer syndrome. The purpose of this study is to offer no cost genetic testing to the general public. Researchers hope to learn the value of providing broad, public-wide testing for high risk cancer types (like hered…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Providence Portland Medical Center, Portland, Oregon
    Locations
    2 in total
    Run by
    OHSU Knight Cancer Institute
  9. Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

    This study examines how certain risk factors (such as age, gender, other medical conditions, and the type of immunotherapy used to treat the cancer) affect whether a patient with a malignant solid tumor will develop mild or serious side effects from the immunotherapy medications. Immunotherapy is t…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Providence Portland Medical Center, Portland, Oregon
    Locations
    849 in total
    Run by
    SWOG Cancer Research Network
  10. A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study

    This clinical trial tests the impact of a culturally-tailored home-based physical activity program on physical fitness in Hispanic or Latino/Latina adolescent and young adult (AYA) childhood cancer survivors. After treatment for cancer, some AYA survivors experience long-term effects from the cance…

    Stage
    Phase 2
    Ages
    15 to 20
    Site
    Legacy Emanuel Children's Hospital, Portland, Oregon
    Locations
    77 in total
    Run by
    Children's Oncology Group

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.